Novo Nordisk A/S (NVO): A Bull Case Theory 

We came across a bullish thesis on Novo Nordisk A/S on r/Valueinvesting by Quorum_Ataraxia. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S’s share was trading at $59.43 as of January 30th. NVO’s trailing and forward P/E were 15.80 and 16.18 respectively according to Yahoo Finance.

5 Countries with the Highest Rates of Diabetes

Photo by Matt C on Unsplash

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical...